These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8720320)

  • 21. Mixed-model QSAR at the glucocorticoid receptor: predicting the binding mode and affinity of psychotropic drugs.
    Spreafico M; Ernst B; Lill MA; Smiesko M; Vedani A
    ChemMedChem; 2009 Jan; 4(1):100-9. PubMed ID: 19009570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacophore-based design, synthesis, biological evaluation, and 3D-QSAR studies of aryl-piperazines as alpha(1)-adrenoceptor antagonists.
    Li MY; Fang H; Xia L
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3216-9. PubMed ID: 15935663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of validated QSAR models of D1 dopaminergic antagonists for database mining.
    Oloff S; Mailman RB; Tropsha A
    J Med Chem; 2005 Nov; 48(23):7322-32. PubMed ID: 16279792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving structure-linked access to publicly available chemical toxicity information.
    Richard AM; Williams CR; Cariello NF
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):136-43. PubMed ID: 11865667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of 3D-QSAR in the rational design of receptor ligands and enzyme inhibitors.
    Mor M; Rivara S; Lodola A; Lorenzi S; Bordi F; Plazzi PV; Spadoni G; Bedini A; Duranti A; Tontini A; Tarzia G
    Chem Biodivers; 2005 Nov; 2(11):1438-51. PubMed ID: 17191945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A program for the optimum design of pharmacokinetic, pharmacodynamic, drug metabolism and drug-drug interaction models.
    Graham G; Gueorguieva I; Dickens K
    Comput Methods Programs Biomed; 2005 Jun; 78(3):237-49. PubMed ID: 15899308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of structure-activity analysis in toxicology].
    Laass W
    Arch Exp Veterinarmed; 1978; 32(4):579-84. PubMed ID: 727870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical structure of mutagens and carcinogens and the relationship with biological activity.
    Benigni R
    J Exp Clin Cancer Res; 2004 Mar; 23(1):5-8. PubMed ID: 15149144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QSAR oriented computer representation of chemical compounds used in CISOC-SARSS.
    Yuan SG; Zhao X; Zeng FY; Zheng CZ
    Prog Clin Biol Res; 1989; 291():195-8. PubMed ID: 2726845
    [No Abstract]   [Full Text] [Related]  

  • 32. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action.
    Ganter B; Tugendreich S; Pearson CI; Ayanoglu E; Baumhueter S; Bostian KA; Brady L; Browne LJ; Calvin JT; Day GJ; Breckenridge N; Dunlea S; Eynon BP; Furness LM; Ferng J; Fielden MR; Fujimoto SY; Gong L; Hu C; Idury R; Judo MS; Kolaja KL; Lee MD; McSorley C; Minor JM; Nair RV; Natsoulis G; Nguyen P; Nicholson SM; Pham H; Roter AH; Sun D; Tan S; Thode S; Tolley AM; Vladimirova A; Yang J; Zhou Z; Jarnagin K
    J Biotechnol; 2005 Sep; 119(3):219-44. PubMed ID: 16005536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds.
    Shen M; Béguin C; Golbraikh A; Stables JP; Kohn H; Tropsha A
    J Med Chem; 2004 Apr; 47(9):2356-64. PubMed ID: 15084134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The application of modern pharmacology to medical practice].
    Scholtholt J
    Fortschr Med; 1980 Aug; 98(30-31):1139-43. PubMed ID: 7419157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding orientations, QSAR, and molecular design of thiophene derivative inhibitors.
    Liao SY; Chen TJ; Miao TF; Qian L; Zheng KC
    Chem Biol Drug Des; 2009 Sep; 74(3):289-96. PubMed ID: 19703031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [QSAR analysis in the transfer of data between biological systems].
    Tichý M
    Cas Lek Cesk; 1982 Sep; 121(34-35):1075-7. PubMed ID: 7127388
    [No Abstract]   [Full Text] [Related]  

  • 38. Estimation of quantal dose response of drugs by the Spearman-Karber method: a computer program written in BASIC.
    Fung KP; Wong TW
    J Singapore Paediatr Soc; 1989; 31(3-4):129-32. PubMed ID: 2638718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The thermodynamic activity coefficient in pharmacology and toxicology].
    Toffoli C; Leonardi R; Oderio A; Toffoli F
    Boll Chim Farm; 1981 May; 120(5):253-72. PubMed ID: 7295385
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative study of lipophilicity versus topological molecular descriptors in biological correlations.
    Basak SC; Harriss DK; Magnuson VR
    J Pharm Sci; 1984 Apr; 73(4):429-37. PubMed ID: 6726623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.